ERBB3 and neoplasm: HerDox treatment also yielded a reduction in tumour HER3 (Supplementary Fig. 38), which taken altogether suggests that HerDox retains the tumoricidal activity of Dox while improving targeted toxicity to brain-localized tumours and preserving healthy brain tissue compared with Lipodox.